Introduction. Carbapenem resistant Enterobacterales (CRE) are one of the leading causes of systemic and nosocomial infections and are multidrug-resistant organisms producing different carbapenemases. There are many genotypic and phenotypic methods for detecting the carbapenemases; however, there is a limitation for each. Modified carbapenem inactivation method (mCIM) assay is a recent phenotypic method which has been published by the Clinical and Laboratory Standards Institute.
Hypothesis / Gap Statement. mCIM assay could provide a reliable method for the detection of carbapenemases in CRE.
Aim. Evaluation of the mCIM assay performance for the detection of carbapenemases in Enterobacterales and the identification of the common carbapenemase genes at Eastern Province of Saudi Arabia and Kingdom of Bahrain.
Methodology. A collection of 197 non-duplicate carbapenem resistant Enterobacterales clinical isolates, were evaluated with the mCIM test comparing its performance to multiplex PCR. The minimum inhibitory concentration susceptibility testing was done by the Etest method for imipenem, meropenem, and ertapenem.
Results. The sensitivity of the mCIM assay was 94 % (95 % CI, (89.3–97.1)). In Saudi Arabia and Bahrain, OXA-48 was the most prevalent carbapenemase gene followed by NDM. Coexistence of multiple carbapenemase genes is reported in eleven cases.
Conclusion. These findings indicate that the mCIM test is a reliable and simple assay for detecting the activity of carbapenemase in Enterobacterales, especially in resource-limited laboratories.
PragasamAK, VeeraraghavanB, BakthavatchalamYD, GopiR, AslamRF. Strengths and limitations of various screening methods for carbapenem-resistant Enterobacteriaceae including new method recommended by Clinical and Laboratory Standards Institute, 2017: A tertiary care experience. Indian J Med Microbiol2017; 35:116–119 [View Article] [PubMed]
van der ZwaluwK, de HaanA, PluisterG, BootsmaH, de NeelingA et al. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLOS ONE2015; 10:e0123690 [View Article] [PubMed]
HammoudiD, Ayoub MoubareckC, Karam SarkisD. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. J Microbiol Methods2014; 107:106–118 [View Article]
CastanheiraM, DeshpandeLM, MendesRE, CantonR, SaderHS et al. Variations in the occurrence of resistance phenotypes and carbapenemase genes among Enterobacteriaceae isolates in 20 years of the sentry antimicrobial surveillance program. Open Forum Infect Dis2019; 6:S23–S33 [View Article] [PubMed]
BalkhyH, El-SaedA, JohaniS, FrancisC, Al-QahtaniA et al. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?. Eur J Clin Microbiol Infect Dis2012; 31:1901–1909 [View Article]
ZowawiH, BalkhyH, WalshT, PatersonD. β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev2013; 26:361–380 [View Article] [PubMed]
ZowawiH, SartorA, BalkhyH, WalshT, Al JohaniS et al. Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf Cooperation council: Dominance of oxa-48 and NDM producers. Antimicrob Agents Chemother2014; 58:3085–3090 [View Article] [PubMed]
TijetN, PatelSN, MelanoRG. Detection of carbapenemase activity in Enterobacteriaceae: Comparison of the carbapenem inactivation method versus the carba NP test. J Antimicrob Chemother2016; 71:274–276 [View Article]
PapstL, BeovićB, PulciniC, Durante-MangoniE, Rodríguez-BañoJ et al. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect2018; 24:1070–1076 [View Article] [PubMed]
Butler-WuSM, AbbottAN. Is this the Carbapenemase test we’ve been waiting for? a multicenter evaluation of the nodified Carbapenem inactivation method. J Clin Microbiol2017; 55:2309–2312 [View Article] [PubMed]
TammaPD, OpeneBNA, GluckA, ChambersKK, CarrollKC et al. Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae. J Clin Microbiol2017; 55:1046–1055 [View Article] [PubMed]
KuchibiroT, KomatsuM, YamasakiK, NakamuraT, NishioH et al. Evaluation of the modified carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae. J Infect Chemother2017; 24:262–266 [View Article] [PubMed]
GirlichD, PoirelL, NordmannP. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol2012; 50:477–479 [View Article] [PubMed]
ZhouM, WangD, KudinhaT, YangQ, YuS et al. Comparative evaluation of four phenotypic methods for detection of class a and B carbapenemase-producing Enterobacteriaceae in China. J Clin Microbiol2018; 56: [View Article] [PubMed]
HawkeyP, WarrenR, LivermoreD, McNultyC, EnochD et al. Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British Society for antimicrobial Chemotherapy/healthcare Infection Society/british Infection Association Joint Working party†. J Ant Chem2018; 73:iii2–iii78 [View Article]
AlotaibiF, BukhariE, Al-MohizeaM, HafizT, EssaE et al. Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes. J Infect Public Health2017; 10:667–673 [View Article]
SonnevendÁ, GhazawiAA, HashmeyR, JamalW, RotimiVO et al. Characterization of carbapenem-resistant Enterobacteriaceae with high rate of autochthonous transmission in the Arabian Peninsula. PLOS ONE2015; 10:e0131372 [View Article]
WangY, TangH, LiaoY, ChiouC, ChenY et al. Cocarriage of distinct Blakpc-2 and BLAOXA-48 plasmids in a single sequence type 11 carbapenem-resistant Klebsiella pneumoniae isolate. Antimicrob Agents Chemother2019; 63: [View Article] [PubMed]
AnJ, LaiK, MaY, GuoL, YeL et al. Emergence of multiple carbapenemase-producing organisms in single patients: An increasing threat to treatment of infection. J Antimicrob Chemother2018; 73:544–546 [View Article]
KhanMA, MohamedAM, FaizA, AhmadJ. Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance. J Infect Dev Ctries2019; 13:334–341 [View Article]
DortetL, NordmannP, PoirelL. Association of the emerging carbapenemase NDM-1 with a bleomycin resistance protein in Enterobacteriaceae and Acinetobacter baumannii. Antimicrob Agents Chemother2012; 56:1693–1697 [View Article] [PubMed]
PoirelL, NaasT, NicolasD, ColletL, BellaisS et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother2000; 44:891–897 [View Article] [PubMed]